AU Patent
AU2004222340A1 — Sinus delivery of sustained release therapeutics
Assigned to Intersect ENT Inc · Expires 2004-09-30 · 22y expired
What this patent protects
Patent listed against Elocon.
Drugs covered by this patent
- Elocon (MOMETASONE FUROATE) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.